People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

24 Sep 2020
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Yanai, Shlomo 

Mr. Shlomo Yanai serves as Independent Director of the Company. Mr. Yanai has more than 15 years of corporate leadership experience, primarily in the pharmaceutical industry. He served as President and Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2007 to 2012. Mr. Yanai currently serves as an advisor to CVC Capital Partners, a private equity firm. In addition, he currently serves on the boards of PDL BioPharma Inc. and WR Grace & Co. He previously served on the boards of Cambrex Corp., Lumenis Ltd., Perrigo Company and Sagent Pharmaceuticals, among others, and held various leadership positions in the Israel Defense Forces.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 35,805
Long-Term Incentive Plans, USD --
All Other, USD 76,358
Fiscal Year Total, USD 112,163

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --